Analytics
The research facility will initially focus on developing AI tech for neurology.
CVS.AI will use information from heart scans to improve the detection and prediction of cardiovascular diseases.
It shows the inner workings of a patient's heart and the impact of their risk factors for heart disease.
The US firm’s software will be rolled out across 30 hospital trusts.
The centralised platform is able to process information from about 50 oncology patients daily.
They first partnered in 2020 to jointly develop hospital applications.
The centre was revalidated after first achieving the status in 2015.
HIMSS Analytics awarded the Saudi Arabian hospital the highest level of validation for inpatient digital maturity.
The NHSX brand will ‘retire very soon’ under new interim arrangements.
HIMSS validated the hospital for its inpatient and outpatient EMR capabilities.